GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » EV-to-EBIT

AddLife AB (OSTO:ALIF B) EV-to-EBIT : 35.20 (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AddLife AB's Enterprise Value is kr19,113 Mil. AddLife AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr543 Mil. Therefore, AddLife AB's EV-to-EBIT for today is 35.20.

The historical rank and industry rank for AddLife AB's EV-to-EBIT or its related term are showing as below:

OSTO:ALIF B' s EV-to-EBIT Range Over the Past 10 Years
Min: 19.7   Med: 31.64   Max: 53.96
Current: 35.2

During the past 11 years, the highest EV-to-EBIT of AddLife AB was 53.96. The lowest was 19.70. And the median was 31.64.

OSTO:ALIF B's EV-to-EBIT is ranked worse than
73.36% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.815 vs OSTO:ALIF B: 35.20

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. AddLife AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr18,909 Mil. AddLife AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr543 Mil. AddLife AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.87%.


AddLife AB EV-to-EBIT Historical Data

The historical data trend for AddLife AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB EV-to-EBIT Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.79 24.85 51.09 25.84 29.84

AddLife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.24 32.38 22.91 29.84 34.82

Competitive Comparison of AddLife AB's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, AddLife AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AddLife AB's EV-to-EBIT falls into.



AddLife AB EV-to-EBIT Calculation

AddLife AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19112.944/543
=35.20

AddLife AB's current Enterprise Value is kr19,113 Mil.
AddLife AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr543 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB  (OSTO:ALIF B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

AddLife AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=543/18908.768
=2.87 %

AddLife AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr18,909 Mil.
AddLife AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr543 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of AddLife AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB (OSTO:ALIF B) Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB (OSTO:ALIF B) Headlines

No Headlines